Chemotherapeutic regulation of the ROS/MondoA-dependent TXNIP/GDF15 axis; and derivation of a new organoid metric as a predictive biomarker
Jinhai Deng(Guangdong Pharmaceutical University), Tony Ng(King's College London)
Cited by 0
Related Papers
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
|Science Signaling|2014|166
Breast cancer–associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells
|Science Signaling|2020|74
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma
|Haematologica|2016|48
Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer
|Theranostics|2023|37
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans
|Cell Death and Disease|2022|30